Zhejiang Medicine Co., Ltd. (600216.SS)
CNY 16.02
(0.5%)
CNY 16.02
(0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.79 Billion | 8.11 Billion | 9.12 Billion | 7.32 Billion | 7.04 Billion | 6.85 Billion |
| Cost of Revenue | 5.26 Billion | 5.31 Billion | 5.39 Billion | 4.28 Billion | 4.17 Billion | 3.98 Billion |
| Gross Profit | 2.52 Billion | 2.79 Billion | 3.72 Billion | 3.04 Billion | 2.87 Billion | 2.87 Billion |
| Operating Expenses | 2.14 Billion | 2.13 Billion | 2.38 Billion | 2.1 Billion | 2.44 Billion | 2.26 Billion |
| Selling, General and Administrative Expenses | 1.16 Billion | 1.01 Billion | 1.24 Billion | 1.29 Billion | 1.72 Billion | 1.65 Billion |
| Research and Development Expenses | 860.07 Million | 809.27 Million | 806.85 Million | 546.09 Million | 450.42 Million | 321.55 Million |
| Other Expenses | -94.05 Million | 314.97 Million | 331.94 Million | 263.65 Million | 266.97 Million | -25.74 Million |
| Cost and Expenses | 7.41 Billion | 7.45 Billion | 7.78 Billion | 6.38 Billion | 6.61 Billion | 6.25 Billion |
| Operating Income | 380.15 Million | 687.82 Million | 1.17 Billion | 882.63 Million | 409.03 Million | 469.12 Million |
| Interest Expense | 28.33 Million | 33.11 Million | 39.53 Million | 46.27 Million | 25.71 Million | 21.03 Million |
| Income Tax Expense | 86.48 Million | 128.77 Million | 268.97 Million | 191.33 Million | 105.54 Million | 116.17 Million |
| Earnings before Tax | 363.27 Million | 491.38 Million | 1.15 Billion | 850.98 Million | 397.49 Million | 443.37 Million |
| Net Income | 429.63 Million | 362.61 Million | 1.04 Billion | 717.39 Million | 342.77 Million | 364.54 Million |
| Earnings Per Share Basic | 0.45 | 0.38 | 1.09 | 0.75 | 0.36 | 0.38 |
| Earnings Per Share Diluted | 0.45 | 0.38 | 1.09 | 0.75 | 0.36 | 0.38 |
| Weighted Average Shares Outstanding | 954.75 Million | 958.3 Million | 958.3 Million | 958.3 Million | 958.3 Million | 959.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 954.75 Million | 958.54 Million | 958.3 Million | 958.3 Million | 958.3 Million | 959.34 Million |
| Gross Margin | 0.32 | 0.34 | 0.41 | 0.42 | 0.41 | 0.42 |
| EBIT Margin | 0.15 | 0.17 | 0.21 | 0.21 | 0.14 | 0.15 |
| Profit Margin | 0.06 | 0.04 | 0.11 | 0.10 | 0.05 | 0.05 |
| EBITDA | 1.13 Billion | 1.21 Billion | 1.78 Billion | 1.4 Billion | 913.48 Million | 895.02 Million |
| Earnings Before Tax Margin | 0.05 | 0.08 | 0.13 | 0.12 | 0.06 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.7 Billion | 2.13 Billion | 2.24 Billion | 1.91 Billion | 7.79 Billion | 1.93 Billion |
| Cost of Revenue | 1.41 Billion | 1.37 Billion | 1.5 Billion | 1.36 Billion | 5.26 Billion | 1.29 Billion |
| Gross Profit | 1.28 Billion | 766.7 Million | 740.35 Million | 551.25 Million | 2.52 Billion | 640.29 Million |
| Operating Expenses | 658.1 Million | 541.05 Million | 599.08 Million | 687.89 Million | 2.36 Billion | 571.6 Million |
| Selling, General and Administrative Expenses | 664.17 Million | 334.5 Million | 403.81 Million | 99.29 Million | - | 550.27 Million |
| Research and Development Expenses | 169.44 Million | 165.7 Million | 196.21 Million | 252.93 Million | - | 177.03 Million |
| Other Expenses | -175.52 Million | -40.84 Million | -753.34 Thousand | -26 Million | -16.87 Million | -9.04 Million |
| Cost and Expenses | 2.07 Billion | 1.91 Billion | 2.1 Billion | 2.05 Billion | 7.63 Billion | 1.86 Billion |
| Operating Income | 595.64 Million | 225.64 Million | 101.79 Million | 120.9 Million | 380.15 Million | 6.43 Million |
| Interest Expense | 6.48 Million | 8.17 Million | 6.8 Million | 7.05 Million | 28.33 Million | 6.87 Million |
| Income Tax Expense | 93.02 Million | 57.54 Million | 21.68 Million | -1.03 Million | 86.48 Million | 11.6 Million |
| Earnings before Tax | 596.21 Million | 242.89 Million | 101.04 Million | 94.89 Million | 363.27 Million | 5.46 Million |
| Net Income | 534.31 Million | 205.68 Million | 109.64 Million | 128.3 Million | 429.63 Million | 29.07 Million |
| Earnings Per Share Basic | 0.56 | 0.21 | 0.11 | 0.13 | - | 0.03 |
| Earnings Per Share Diluted | 0.56 | 0.21 | 0.11 | 0.13 | - | 0.03 |
| Weighted Average Shares Outstanding | 961.63 Million | 961.63 Million | 996.81 Million | 954.66 Million | 954.75 Million | 954.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 961.63 Million | 961.63 Million | 996.81 Million | 954.66 Million | 954.75 Million | 954.65 Million |
| Gross Margin | 0.48 | 0.36 | 0.33 | 0.29 | 0.32 | 0.33 |
| EBIT Margin | 0.22 | 0.19 | 0.06 | -0.08 | - | 0.03 |
| Profit Margin | 0.20 | 0.10 | 0.05 | 0.07 | 0.06 | 0.01 |
| EBITDA | 602.69 Million | 406.33 Million | 143.8 Million | -161.69 Million | - | 50.43 Million |
| Earnings Before Tax Margin | 0.22 | 0.11 | 0.05 | 0.06 | 0.05 | 0.00 |
FLEW
GAME
600829
2314
ELISA
688256